ATN-161

DRUG2 trials

Sponsors

Attenuon, National Institutes of Health Clinical Center (CC)

Conditions

Brain and Central Nervous System TumorsCarcinoma, Renal Cell

Phase 1

ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma

CompletedNCT00352313

National Institutes of Health Clinical Center (CC)Brain and Central Nervous System Tumors

Start: 2006-05-31End: 2008-01-31Target: 82Updated: 2012-05-02

Phase 2

ATN-161 in Advanced Renal Cell Cancer

TerminatedNCT00131651

AttenuonCarcinoma, Renal Cell

Start: 2005-08-31Target: 36Updated: 2007-12-06